FDA Clears Toshiba’s Latest Dose Reduction Software
Adaptive Iterative Dose Reduction (ADIR) 3D, the third generation software, will be offered to existing Aquilion One, Premium, and Prime CT customers.
Toshiba America Medical Systems Inc.’s latest dose reduction software, Adaptive Iterative Dose Reduction (ADIR) 3D, has received FDA clearance, the company announced.
The third generation software, which Toshiba will offer to existing Aquilion One, Premium, and Prime CT customers, reduces radiation dose compared to conventional scanning, the company said. The algorithm, designed to work in raw data and imaging data space, reduces noise while attempting to maintain image quality.
The ADIR 3D can be integrated with Sure Exposure 3D, software that calculates the minimum radiation exposure required for every exam based on pre-set targeted level of image quality.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
